Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 February 2018 Photo Eugene Seegers
Dutch scholar honours Faculty of Theology and Religion with special book dedication
Prof Bram van de Beek hands over his book, Mijn Vader, uw Vader, which contains his dedication to the UFS Faculty of Theology and Religion, to Prof Fanie Snyman, Dean of the faculty.

While surveying recent publications, staff members at the Faculty of Theology and Religion discovered, almost by coincidence, that a world-renowned systematic theologian and professor emeritus of the Free University Amsterdam (VU Amsterdam) in the Netherlands, Prof Bram van de Beek, had dedicated his most recent volume on Systematic Theology to the Faculty of Theology and Religion at the UFS in Bloemfontein.

Even before Prof Fanie Snyman, Dean of this faculty, had any knowledge of this special honour, Prof Van de Beek was invited to conduct the Scripture reading and sermon on the programme of the University of the Free State (UFS) Faculty of Theology and Religion’s official opening and Theological Day. This event provided the perfect opportunity for Prof Van de Beek to officially hand a copy of his book over to the faculty.

Prof Van de Beek accepted the invitation and on 19 February 2018 conducted the sermon in the Odeion Theatre at the UFS based on the theme of the Theological Day, Reconciliation: Biblical imperative and the South African reality. He then formally presented his book, with the title Mijn Vader, uw Vader, which contains the dedication, to Prof Snyman, saying: “It is an honour for me to have the opportunity to present my book today. It was a pleasure for me to dedicate it to the Faculty of Theology and Religion in Bloemfontein. I did so because of my great appreciation for the work these colleagues are doing.”

'It was a pleasure for me
to dedicate this book to the
UFS Faculty of Theology and Religion.'
—Prof Bram van de Beek
Dutch Systematical Theologian
and Dogmatician

Prof Van de Beek continued: “They keep to academic standards in difficult circumstances. It is not only the pressure of ‘publish or perish’ which must be resisted, but also the pressure of society, and most of all, of church members who want an adapted theology according to their desires. True theology, like any academic discipline, is interested in the truth and is not based on interests. I notice the courage by colleagues of this faculty to keep to this standard in both the training of students and in their research. They even had the courage to reflect on the very rationale of the existence of theology at a public university. Nothing can be taken for granted, for at the very moment we do so in the university, we lose our critical attitude, which is the basis for academic work. So it is with great esteem that I dedicated my book to this faculty.”

In his acceptance, Prof Snyman expressed his utmost appreciation that a European theologian of worldwide renown would take note of a university and faculty so far removed from his sphere of activity.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept